Osim International (O23.SG) off 2.9% at $1.67 in active trade, falling back after hitting $1.74 at the open, its highest level since late 2006, as despite its strong 4Q, FY results, investors are likely uneasy about pushing the price higher after the stock’s 215% surge since the start of 2010.
Posts Tagged ‘osim’
Jan 27: Ascendas India, City Developments, Osim
January 27th, 2011 |
No Comments
The following companies may have unusual price changes in Singapore trading. Stock symbols are in parentheses, and share prices are from the previous close. Singapore’s Straits Times Index climbed 1.3% to 3,220.78.
Ascendas India Trust (AIT SP): The operator of business parks in India said third-quarter income for distribution fell 7% to $13.2 million from a year ago. The stock gained 0.5% to 96 cents.
Jan 27: Singapore stocks may rise slightly but Fed weighs; Osim in focus
January 27th, 2011 |
No Comments
Singapore shares may open slightly higher on Thursday, following gains on Wall Street overnight, but a tepid view of the economy from the Federal Reserve may weigh on investor confidence.
Singapore’s benchmark Straits Times Index <.FTSTI> rose 1.25% at 3,220.78 points.
Here are some stocks to watch:
Osim International 4Q net income doubles, sales fall
January 26th, 2011 |
No Comments
Osim International said its fourth-quarter net income more than doubled to $17 million from $8 million a year earlier.
Sales in the quarter declined 6% to $133 million from $141 million, the company said in a statement to the Singapore stock exchange today.
{jcomments on}
Osim +1.8%; China buy in line with strategy – OCBC
January 3rd, 2011 |
No Comments
Osim International (O23.SG) is up 1.8% at $1.67, outperforming the broader market amid a positive reaction to the massage chair maker’s strategic acquisition in China.
Osim announces it has purchased a 19.03% stake in Hong Ming (China) for US$313,585, raising its total effective stake in Hong Ming to 30.0%. Osim says Hong Ming is one of the R&D arms of associated company Daito-OSIM Healthcare and that the buy is accretive but not expected to have any material impact on EPS and NTA for FY10.
Osim cut to Neutral by DMG on valuation grounds
December 10th, 2010 |
No Comments
DMG downgrades Osim (O23.SG) to Neutral from Buy as the stock has breached its $1.66 target price.
Says the shares, based on yesterday’s $1.70 close, are now worth 18.5x FY11 P/E, the average multiple from 2006-2008.
Dec 10: Genting, Tiger Air, Osim, Bio-Treat, SIA Engineering
December 10th, 2010 |
No Comments
Singapore shares may open slightly higher on Friday after Wall Street edged up overnight, with the benchmark S&P 500 closing at a two-year high, a trend investors expect to continue through the rest of the year. Singapore’s benchmark Straits Times Index <.FTSTI> was up 0.23 percent on Thursday to 3,210.20 points. Here are some stocks to watch, say Bloomberg and Thomson Reuters.
Genting Singapore (GENS.SI) may be in focus as its Resorts World at Sentosa casino is seeking to borrow around $4.2 billion ($3.2 billion) to pay off an existing loan, Reuters basis point reported on Thursday.
Osim International rated ‘buy’ by DMG
December 6th, 2010 |
No Comments
DMG & Partners Securities in a Dec 3 research report says: “OSIM plans to offer and list Taiwan Depository Receipts (TDRs) on the Taiwan Stock Exchange (TSE).
Dec 2: Capitaland, Cosco, SIA, Noble, Osim, United Engineers
December 2nd, 2010 |
No Comments
Singapore shares may open higher on Thursday after Wall Street posted its biggest gains in three months overnight, as efforts to resolve the EU’s debt crisis helped push the S&P above 1,200, an important technical level. Singapore’s benchmark Straits Times Index <.FTSTI> rose 1.18% on Wednesday to 3,181.94 points. Here are some stocks and factors to watch, say Bloomberg and Dow Jones:
Capitaland (CAPL SP): Southeast Asia’s biggest developer plans to introduce an average of 3,000 residential units in China annually as part of its growth strategy in the country, the Singapore-based company said in investor briefing materials filed to the Singapore stock exchange. It said it also plans to expand the number of its serviced residences in the country to 12,000 units by 2015, from 6,246 currently. The shares gained 1.4% to $3.66.
Osim International rated ‘buy’ by DMG
October 22nd, 2010 |
No Comments
DMG & Partners Securities in an Oct 21 research report says: “OSIM reported 3QFY10 profit after tax and minority interest (PATMI) of $13.0 million (+85.5% y-o-y, +7.6% q-o-q) on the back of $116.7 million in revenue (-4.8% y-o-y, – 10.7% q-o-q).
Osim posts 86% rise in 3Q earnings to $13m
October 21st, 2010 |
No Comments
Massage chair maker Osim says it has earned $13 million for the third quarter ended September, 86% more than the year before.
Sales were down marginally at $117 million, and the company attributes this to the conversion of health supplement chain GNC Australia’s conversion into franchised outlets.
OSIM up on broker’s target price increase
October 21st, 2010 |
No Comments
Shares of massage chair maker OSIM International <OSIL.SI> rose as much as 3.7% on Thursday after DMG & Partners raised its target price to $1.57 from $1.32 and maintained its “buy” rating.
At 0319 GMT, OSIM shares were trading at $1.13 on a volume of 6 million shares.
DMG raises Osim target to $1.52; Keeps Buy
October 20th, 2010 |
No Comments
DMG keeps Osim International (O23.SG) at Buy, raises target price to $1.52 from $1.37 after revising up FY10-FY12 earnings estimates by 20%-24% to take into account higher margins arising from better product mix, economies of scale, improved profitability in GNC Australia business.
Oct 20: NOL, CapitaRetail China Trust, Osim, Keppel T&T, BH Global Marine
October 20th, 2010 |
No Comments
Singapore shares are likely to fall on Wednesday, as China’s surprise move to raise rates sent investors scrambling to safe haven assets, amid worries that tightening credit could weigh on an uncertain economic recovery. Singapore’s benchmark Straits Times Index <.FTSTI> rose 0.35% on Tuesday to 3,192.29 points.
Osim +1.5%; Thin newsflow may cap upside near-term
September 27th, 2010 |
No Comments
Osim (O32.SG) +1.5% at $1.01 but struggling to hold above $1.00, according to Dow Jones.
While stock has recouped bulk of its 15.7% fall over first 3 weeks of last month, when it dropped to $0.91 on August 18 from 52-week high of $1.08 set August 2, rebound has been choppy despite several bullish analyst reports on massage-chair maker.
Investors generally preferring to wait for more news flow, which has been thin since release of 2Q10 results in July.
Osim CEO Sim targets brand acquisitions to bolster China sales
September 1st, 2010 |
No Comments
Osim International, Asia’s biggest maker of massage chairs outside of Japan, plans to acquire Asian health and lifestyle brands and bring them into China to increase its presence in the country.
The growing affluence of young female Chinese customers is a potential market for Osim’s so-called specialty retail products, founder and Chief Executive Officer Ron Sim said in an interview yesterday.
Osim +2.2%; Recent fall not justified: Macquarie
August 19th, 2010 |
No Comments
Osim (O23.SG) +2.2% at $0.93, may end up for first time in 4 sessions on broad market uptick, says Dow Jones.
Shares down 6.7% so far this week after going ex-dividend on Tuesday, but down by even steeper 14.2% so far this month.
“We find no justification for such a sharp fall and see this as an excellent opportunity to enter the stock,” says Macquarie, which has Outperform call with $1.50 target; notes massage-chair maker deserves re-rating given improving profitability in key markets, strong net cash position.
OSIM International rated buy by OCBC
July 22nd, 2010 |
No Comments
OCBC Investment Research in a July 21 research report says: “OSIM delivered a good set of 2Q10 results last evening. While revenue of $130.7 million (+11.6% y-o-y) came in slightly below our expectation, PATMI of $12.1 million (+141.2% y-o-y) exceeded our projection significantly due to higher margins from product innovation and better operating efficiency.
Weekend Comment Dec 3: Osim goes to Taiwan
The TDR listing aims to broaden and diversify the company’s shareholder base and provide it with an additional fund-raising platform for future expansion. Osim had previously mentioned that it would consider acquiring new brands in China to boost its presence in that country. The listing will also “strengthen public awareness of the Osim brand in Taiwan, which has been a key market for Osim products since 1987,” the company said in a statement on Dec 2.
Read more…